CC
CL icon

Centiva Capital’s Colgate-Palmolive CL Stock Holding History

Centiva Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,300
Closed -$1.74M – 2112
2024
Q1 		$1.74M Sell
19,300
-30,000
-61% -$2.54M 0.04% 392
2023
Q4 		$3.93M Sell
49,300
-12,500
-20% -$940K 0.09% 204
2023
Q3 		$4.39M Buy
61,800
+12,500
+25% +$935K 0.1% 184
2023
Q2 		$3.8M Buy
+49,300
New +$3.82M 0.08% 246
2019
Q1 		– Sell
-12,400
Closed -$738K – 320
2018
Q4 		$738K Sell
12,400
-4,000
-24% -$250K 0.06% 165
2018
Q3 		$1.1M Buy
+16,400
New +$1.09M 0.09% 100

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Centiva Capital's CL Position: Q3 2025 in Review

Centiva Capital sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 7,365 shares — an estimated $669K sold.

Centiva Capital first reported a position in CL in Q3 2018 and held it in 15 quarters. The position peaked at $3.65M in Q2 2023. 1,843 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Centiva Capital reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 7,365 Colgate-Palmolive shares in Q3 2025, an estimated $669K.
  • Centiva Capital first reported a position in Colgate-Palmolive in Q3 2018 and held it in 15 quarters.
  • Centiva Capital's Colgate-Palmolive position peaked at $3.65M in Q2 2023.
  • 1,843 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.